Carolina Infusion Care is categorized under Home Health Care Services in Charlotte, NC .
Carolina Infusion Care was established in 0, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Home Health Care Services business, which does work in the B2C market, and is classified as a Home Health Care Services, under code number 6216100 by the NAICS.
If you are seeking more information, feel free to contact Ed Devruyna, Manager at the company’s branch by writing to 13504 South Point Boulevard # H, Charlotte, North Carolina NC 28273 or by phoning (704) 583-2140. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Carolina Infusion Care |
| Contact Person: | Ed Devruyna, Manager |
| Address: | 13504 South Point Boulevard # H, Charlotte, North Carolina 28273 |
| Phone Number: | (704) 583-2140 |
| Website Address: | gentiva.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Location Type: | Branch |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Home Health Care Services |
| SIC Code: | 8082 |
| NAICS Code: | 6216100 |
| Share This Business: |
Carolina Infusion Care was started in 0 to provide professional Home Health Care Services under the SIC code 8082 and NAICS code 6216100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Ed Devruyna, Manager for inquiries that concern Carolina Infusion Care by calling the company number (704) 583-2140, as your correspondence is most welcome. Additionally, the physical location of the branch of Carolina Infusion Care can be found at the coordinates 35.11048,-80.95769 as well as the street address 13504 South Point Boulevard # H in Charlotte, North Carolina 28273.
For its online presence, you may visit Carolina Infusion Care’s website at gentiva.com and engage with its social media outlets through on Twitter and on Facebook.